MOLECULAR ANALYSIS OF THE RETINOBLASTOMA (RB1) GENE IN ACUTE MYELOID-LEUKEMIA PATIENTS

Citation
Mb. Demelo et al., MOLECULAR ANALYSIS OF THE RETINOBLASTOMA (RB1) GENE IN ACUTE MYELOID-LEUKEMIA PATIENTS, Leukemia research, 22(9), 1998, pp. 787-792
Citations number
45
Categorie Soggetti
Oncology,Hematology
Journal title
ISSN journal
01452126
Volume
22
Issue
9
Year of publication
1998
Pages
787 - 792
Database
ISI
SICI code
0145-2126(1998)22:9<787:MAOTR(>2.0.ZU;2-H
Abstract
The pathogenesis of acute leukemia is still poorly understood. In the past few years several groups have reported deletion of the RB1 gene o r altered pRB expression in certain hematologic malignancies, suggesti ng a possible role of RB1 gene inactivation in the process of leukemog enesis. Most studies regarding structural abnormalities of the RB1 gen e indicate that gross deletions or rearrangements are present in a sma ll percentage of patients with acute myeloid leukemia (AML), as is the case with retinoblastoma, where the majority of RB1 gene abnormalitie s are attributed to point mutations. To investigate if such point muta tions in the RB1 gene may have a role in leukemogenesis in AML, we scr eened the RB1 gene of 36 AML patients using conformation-sensitive gel electrophoresis (CSGE). No point mutations were found in the 27 exons , their flanking intron regions or in the promoter region in any of th e 36 patients. Thus, according to our findings, the susceptibility in these patients for developing AML does not appear to be related to poi nt mutations in the RB1 gene. While screening for point mutations, we identified a number of new and previously noted neutral sequence varia tions indicating the efficiency and sensitivity of CSGE in identifying small changes in the RB1 gene. (C) 1998 Elsevier Science Ltd. All rig hts reserved.